scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YGYNO.2010.11.049 |
P698 | PubMed publication ID | 21324515 |
P50 | author | Barbara A. Goff | Q79148245 |
P2093 | author name string | Leona A Holmberg | |
Dan Veljovich | |||
P2860 | cites work | Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer | Q28346751 |
Are DNA ploidy and epidermal growth factor receptor prognostic factors for untreated ovarian cancer? A prospective study | Q74015417 | ||
P433 | issue | 2 | |
P921 | main subject | ovarian cancer | Q172341 |
erlotinib | Q418369 | ||
fallopian tube carcinoma | Q18554948 | ||
uterine tube | Q1233836 | ||
fallopian tube cancer | Q4818922 | ||
P304 | page(s) | 426 | |
P577 | publication date | 2011-02-15 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer | |
P478 | volume | 121 |
Q33637787 | Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells |
Q98164379 | Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence |
Q34306004 | Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells |
Search more.